E. Genazzani

发表

Prolactin receptors in human choroid plexus.

M. Papotti, G. Muccioli, R. Carlo, 1998 .

Pituitary modulation of sulpiride action in the central nervous system of the rat

R. Carlo, E. Genazzani, A. Crispino, 1978, Neuroscience Letters.

HISTAMINE‐SENSITIVE ADENYLATE CYCLASE IN HYPOTHALAMUS OF RAT BRAIN: H1 AND H2 RECEPTORS

E. Genazzani, A. Crispino, P. Portaleone, 1978, Journal of neurochemistry.

Differential effects of indolepyruvic acid and 5-hydroxytryptophan on indole metabolism in the pineal gland of the rat during the light-dark cycle.

C. Ferretti, P. Ghi, E. Genazzani, 1990, European journal of pharmacology.

Vaccinium myrtillus anthocyanosides are inhibitors of cAMP and cGMP phosphodiesterases

C. Ferretti, P. Ghi, M. Magistretti, 1988 .

Further study on the changes in the concentration of prolactin-binding sites in different organs of Xenopus laevis male and female, kept under dry conditions and then returned to water (their natural habitat).

G. Muccioli, E. Genazzani, A. Guardabassi, 1989, General and comparative endocrinology.

Prolactin receptors on large granular lymphocytes: Dual regulation by cyclosporin A

A. Cesano, G. Muccioli, L. Matera, 1988, Brain, Behavior, and Immunity.

Phosphatidylserine activity on prolactin brain receptors of aged rabbits

G. Muccioli, C. Ghe', R. Carlo, 1988, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Enhancement of pentobarbital narcosis by drugs competing on the serum protein binding.

R. Di Carlo, F. Di Carlo, E. Genazzani, 1971, Biochemical pharmacology.

In primary neuronal cultures muscarinic m1 and m3 receptor mRNA levels are regulated by agonists, partial agonists and antagonists.

R. Brusa, C. Eva, E. Genazzani, 1995, European journal of pharmacology.

Interaction of cardiac glycosides with serum albumin and contractile proteins

E. Genazzani, R. Santamaria, 1969 .

3H-N-methylscopolamine binding to human lymphocytes. A model to study cholinergic dysfunction in Alzheimer's disease

B. Bergamasco, P. Rocca, L. Ravizza, 1988 .

Down regulation of muscarinic receptor subtypes messenger RNA in rat primary culture of corticostriatal neurons.

A. Oberto, R. Brusa, R. Peila, 1992, Pharmacological research.

Downregulation of muscarinic receptor subtypes messenger RNA in rat primary culture of corticostriatal neurons : V meeting of the Inter-Regional Group Liguria, Lombardia, Piemonte, Valle d'Aosta of the Italian Society of Pharmacology, Brescia, May 24, 1991

A. Oberto, R. Brusa, R. Peila, 1992 .

INFLUENCE OF DIFFERENT DRUGS ON THE SULFONAMIDES SERUM BINDING AND ON SULFONAMIDE AQUEOUS HUMOR LEVELS

R. Carlo, E. Genazzani, G. Pagnini, 1968 .

An analysis of lymphocyte 3H-N-methyl-scopolamine binding in neurological patients. Evidence of altered binding in Alzheimer's disease.

B. Bergamasco, P. Rocca, L. Ravizza, 1991, Brain : a journal of neurology.

[3 H]N-methylscopolamine binding to muscarinic receptors in human peripheral blood lymphocytes: Characterization, localization on T-lymphocyte subsets and age-dependent changes

P. Rocca, L. Ravizza, P. Ferrero, 1989, Neuropharmacology.

Pharmacokinetics of norfloxacin in healthy volunteers and patients with renal and hepatic damage

I. Viano, M. Eandi, E. Genazzani, 1983, European Journal of Clinical Microbiology.

Changes in the binding affinity of pirenzepine to rat brain muscarinic receptors as a function of age

G. Muccioli, C. Ghe', E. Genazzani, 1987 .

The murine NPY‐1 receptor gene Structure and delineation of tissue‐specific expression

R. Sprengel, A. Oberto, C. Eva, 1992, FEBS letters.

Nerve growth factor modulates the expression of muscarinic cholinergic receptor messenger RNA in telencephalic neuronal cultures from newborn rat brain.

A. Leon, C. Eva, C. Bono, 1992, Brain research. Molecular brain research.

Pharmacological modulation of steroid action

W. Mainwaring, E. Genazzani, F. Carlo, 1980 .

Are the catecholestrogens involved in estrogen-induced striatal dopamine receptor supersensitivity?

G. Gaietta, G. Barrera, G. Barrera, 1989, European journal of pharmacology.

[Recent studies on mechanism of action of ACTH].

A. Morelli, E. Genazzani, 1952, Archivio di scienze biologiche.

[The pharmacology of ATP].

E. De Nito, E. Genazzani, 1953, Il Policlinico. Sezione pratica.

Hypothalamic H1 and H2 receptors: a tool to investigate the neuroendocrine role of histamine.

F. Di Carlo, E. Genazzani, P. Portaleone, 1980, Pharmacological Research Communications.

A Short-Term Chemosensitivity Test with Different Labeled Precursors of DNA or Protein Synthesis: Correlation with Clinical Response

I. Viano, V. Infelise, L. Silvestro, 1986, Tumori.

43 – PHARMACOLOGICAL RESEARCH ON PRAZOSIN

R. Carlo, E. Genazzani, P. Portaleone, 1978 .

Intracerebroventricular administration of nerve growth factor affects muscarinic cholinergic receptors in the cerebral cortex of neonatal rats

G. Vantini, R. Brusa, C. Eva, 1994, Neurochemistry International.

Dihydroergokryptine (DEK) in the Prophylaxis of Common Migraine: Double-Blind Clinical Study vs Placebo

P. Canonico, U. Scapagnini, E. Genazzani, 1989 .

BINDING CAPABILITY OF VARIOUS SULFONAMIDES TO SERUMS OF DIFFERENT ANIMAL SPECIES.

E. Genazzani, G. Pagnini, 1963, American journal of veterinary research.

Molecular mechanisms of homologous desensitization and internalization of muscarinic receptors in primary cultures of neonatal corticostriatal neurons.

E. Costa, C. Eva, E. Genazzani, 1990, The Journal of pharmacology and experimental therapeutics.

Tamoxifen counteracts estradiol induced effects on striatal and hypophyseal dopamine receptors.

C. Ferretti, P. Ghi, S. Racca, 1988, Life sciences.

Induction of 2'-5' oligoadenylate synthetase and activation of ribonuclease in tamoxifen treated human breast cancer cell lines.

I. Viano, F. Di Carlo, C. Dianzani, 1989, Journal of biological regulators and homeostatic agents.